Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

By Guiso N.   Capiau C.   Carletti G.   Poolman J.   Hauser P.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2366-2376

Elsevier

Access to resources Recommend Favorite

Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection

By Denoel P.   Poolman J.   Carletti G.   Veitch K.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2551-2555

Elsevier

Access to resources Recommend Favorite

Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model

By Watanabe M.   Komatsu E.   Abe K.   Iyama S.   Sato T.   Nagai M.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1429-1434

Elsevier

Access to resources Recommend Favorite

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens

By van den Berg B.M.   David S.   Beekhuizen H.   Mooi F.R.   van Furth R.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1118-1128

Elsevier

Access to resources Recommend Favorite

An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines

By Xing D.K.L.   Das R.G.   Williams L.   Canthaboo C.   Tremmil J.   Corbel M.J.  

Vaccine, Vol. 17, Iss. 6, 1999-02 ,pp. : 565-576

Elsevier

Access to resources Recommend Favorite